JP2011526608A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011526608A5 JP2011526608A5 JP2011515493A JP2011515493A JP2011526608A5 JP 2011526608 A5 JP2011526608 A5 JP 2011526608A5 JP 2011515493 A JP2011515493 A JP 2011515493A JP 2011515493 A JP2011515493 A JP 2011515493A JP 2011526608 A5 JP2011526608 A5 JP 2011526608A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- heparin
- composition according
- ulcer
- life
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 208000025865 Ulcer Diseases 0.000 claims 6
- 230000001684 chronic effect Effects 0.000 claims 6
- 229960002897 heparin Drugs 0.000 claims 6
- 229920000669 heparin Polymers 0.000 claims 6
- 231100000397 ulcer Toxicity 0.000 claims 6
- 239000003055 low molecular weight heparin Substances 0.000 claims 5
- 229940127215 low-molecular weight heparin Drugs 0.000 claims 5
- 206010011985 Decubitus ulcer Diseases 0.000 claims 2
- 208000008960 Diabetic foot Diseases 0.000 claims 2
- 208000004210 Pressure Ulcer Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200802002A ES2340902B1 (es) | 2008-07-01 | 2008-07-01 | Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas. |
| ESP200802002 | 2008-07-01 | ||
| PCT/ES2009/070264 WO2010000904A1 (es) | 2008-07-01 | 2009-06-30 | Composición farmacéutica con glicosaminoglicanos y su uso en tratamiento de úlceras crónicas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011526608A JP2011526608A (ja) | 2011-10-13 |
| JP2011526608A5 true JP2011526608A5 (enExample) | 2014-08-07 |
Family
ID=41319881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011515493A Pending JP2011526608A (ja) | 2008-07-01 | 2009-06-30 | グリコサミノグリカンを含む医薬組成物及び慢性潰瘍の処理へのその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20110201572A1 (enExample) |
| EP (1) | EP2308497B1 (enExample) |
| JP (1) | JP2011526608A (enExample) |
| CN (1) | CN102176915A (enExample) |
| AU (1) | AU2009265623B2 (enExample) |
| BR (1) | BRPI0913839A2 (enExample) |
| CA (1) | CA2766483C (enExample) |
| CY (1) | CY1115780T1 (enExample) |
| DK (1) | DK2308497T3 (enExample) |
| ES (2) | ES2340902B1 (enExample) |
| MX (1) | MX2010014552A (enExample) |
| PL (1) | PL2308497T3 (enExample) |
| PT (1) | PT2308497E (enExample) |
| RU (1) | RU2011103459A (enExample) |
| WO (3) | WO2010000905A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2357601B1 (es) | 2011-01-26 | 2012-03-21 | Laboratorios Farmacéuticos Rovi, S.A. | Procedimiento de preparación de derivados de glicosaminoglicanos donadores de óxido n�?trico y su uso en tratamiento de úlceras crónicas. |
| JP2012245943A (ja) * | 2011-05-31 | 2012-12-13 | Hitachi Automotive Systems Ltd | 制御装置 |
| JP5942133B2 (ja) * | 2012-09-11 | 2016-06-29 | 学校法人関西文理総合学園 | 蛍光プローブ及びこれを用いた酵素活性検出方法 |
| EP3271405A1 (en) * | 2015-03-20 | 2018-01-24 | Aarhus Universitet | Inhibitors of pcsk9 for treatment of lipoprotein metabolism disorders |
| EP3273239A1 (en) | 2016-07-19 | 2018-01-24 | Laboratorios Farmacéuticos Rovi, S.A. | Procedure of analysis of glycosaminoglycans, heparins and their derivatives by nuclear magnetic resonance |
| KR20200083974A (ko) * | 2017-09-05 | 2020-07-09 | 엑셀 메드, 엘엘씨 | 허혈 치료용 헤파린 조성물 |
| KR20220092493A (ko) | 2019-09-06 | 2022-07-01 | 콘세호 나시오날 데 인베스티가시오네스 시엔티피카스 이 테크니카스 (코니셋) | 국소 상처 치료용 약학적 조성물 |
| CN114072430B (zh) * | 2020-04-27 | 2023-07-28 | 罗威制药股份有限公司 | 低分子量肝素获取程序以及由此获得的低分子量肝素 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6004A (en) * | 1849-01-09 | chinnqck | ||
| AU529432B2 (en) * | 1977-08-08 | 1983-06-09 | Choay S.A. | Heparin compositions freed of mineral salts, particularly oxalates, and process for obtaining them |
| CA1136620A (en) * | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
| FR2482611B1 (fr) * | 1980-05-14 | 1986-03-07 | Pharmindustrie | Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments |
| IT1245907B (it) * | 1991-05-17 | 1994-10-25 | Alfa Wassermann Spa | Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica. |
| CA2310422A1 (en) * | 1997-11-20 | 1999-06-03 | Ikuo Yamashina | Low-molecular heparin modification and remedy for skin ulcer |
| ES2161615B1 (es) * | 1999-07-23 | 2003-03-16 | Rovi Lab Farmaceut Sa | Composiciones de heparinas de muy bajo peso molecular. |
| EP1357931A2 (en) | 2001-01-08 | 2003-11-05 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
| CU23043A1 (es) | 2001-12-20 | 2005-05-20 | Ct Ingenieria Genetica Biotech | Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico. |
| EP1499317A1 (en) | 2002-05-02 | 2005-01-26 | Pfizer Products Inc. | Treatment of diabetes and diabetic complications with nhe-1 inhibitors |
| US20060040896A1 (en) * | 2004-08-18 | 2006-02-23 | Paringenix, Inc. | Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity |
| CU23388B6 (es) | 2006-01-31 | 2009-07-16 | Ct Ingenieria Genetica Biotech | Composición farmacéutica de microesferas para prevenir la amputación del pie diabético |
-
2008
- 2008-07-01 ES ES200802002A patent/ES2340902B1/es not_active Expired - Fee Related
-
2009
- 2009-06-30 JP JP2011515493A patent/JP2011526608A/ja active Pending
- 2009-06-30 WO PCT/ES2009/070265 patent/WO2010000905A1/es not_active Ceased
- 2009-06-30 EP EP09772593.1A patent/EP2308497B1/en active Active
- 2009-06-30 US US13/001,895 patent/US20110201572A1/en not_active Abandoned
- 2009-06-30 AU AU2009265623A patent/AU2009265623B2/en not_active Ceased
- 2009-06-30 BR BRPI0913839A patent/BRPI0913839A2/pt not_active Application Discontinuation
- 2009-06-30 ES ES09772593.1T patent/ES2476966T3/es active Active
- 2009-06-30 RU RU2011103459/15A patent/RU2011103459A/ru unknown
- 2009-06-30 PT PT97725931T patent/PT2308497E/pt unknown
- 2009-06-30 DK DK09772593.1T patent/DK2308497T3/da active
- 2009-06-30 CA CA2766483A patent/CA2766483C/en not_active Expired - Fee Related
- 2009-06-30 WO PCT/ES2009/070264 patent/WO2010000904A1/es not_active Ceased
- 2009-06-30 CN CN2009801338633A patent/CN102176915A/zh active Pending
- 2009-06-30 PL PL09772593T patent/PL2308497T3/pl unknown
- 2009-06-30 MX MX2010014552A patent/MX2010014552A/es active IP Right Grant
- 2009-06-30 WO PCT/ES2009/070266 patent/WO2010000906A1/es not_active Ceased
-
2013
- 2013-09-05 US US14/018,840 patent/US9211305B2/en not_active Expired - Fee Related
-
2014
- 2014-07-14 CY CY20141100529T patent/CY1115780T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009029622A3 (en) | Antiviral drugs for treatment of arenavirus infection | |
| NO20084919L (no) | Oksadiazolidindionforbindelse | |
| CY1121853T1 (el) | Συνδυαστικη θεραπεια για την αγωγη του διαβητη | |
| WO2013123215A3 (en) | Antiviral drugs for treatment of arenavirus infection | |
| CY1115350T1 (el) | Χρησεις αναστολεων της dpp iv | |
| CY1118099T1 (el) | Δισκια οξεικης ουλιπρισταλης | |
| MX2008012017A (es) | Pirazoles como inhibidores de 11-beta-hsd1. | |
| JP2016530291A5 (enExample) | ||
| RU2011103459A (ru) | Фармацевтическая композиция с гликозаминогликанами и ее применение при лечении хронических язв | |
| JP2009541479A5 (enExample) | ||
| WO2004045618A3 (de) | Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung | |
| CL2010001358A1 (es) | Composicion farmaceutica que comprende un vehiculo farmaceuticamente aceptable y una combinacion de dos dosis de pramipexol y rasagilina, en donde la combinacion a dosis fija contiene desde 0,06 a menos de 1,5 mg de pramipexol y desde 0,05 mg a menos de 1,0 mg de rasagilina. | |
| WO2007082808A3 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
| EA200802247A1 (ru) | Схема дозирования кладрибина для лечения рассеянного склероза | |
| EA201200968A1 (ru) | Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин | |
| JP2017014206A5 (enExample) | ||
| TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
| JP2018172440A5 (enExample) | ||
| JP2015516419A5 (enExample) | ||
| WO2011039780A3 (en) | Topical formulation for diabetic foot ulcers | |
| MX2007013876A (es) | Uso de inhibidor de la via del factor de tejido para tratar infecciones bacterianas severas. | |
| TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
| JP2009516719A5 (enExample) | ||
| RU2008117303A (ru) | Применение активаторов растворимой гуанилатциклазы для лечения острых и хронических легочных заболеваний | |
| UY32670A (es) | Utilizacion de alfa -1-antitripisina para la preparacion de medicamentos para el tratamiento del sindrome de fatiga cronica |